Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6816514 | 7463760 | I | 6816514-0 | 20100318 | 20100617 | 20100630 | EXP | TCI2010A02337 | TAKEDA PHARMACEUTICALS NORTH AMERICA | YR | M | N | 20100628 | JAPAN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6816514 | 1014032852 | PS | ACTOS | 1 | ORAL | (1 IN 1 D) PER ORAL | D | 21073 | |||
| 6816514 | 1014082670 | SS | MP-513 (CODE NOT BROKEN) (ORAL ANTIDIABETICS) | 2 | ORAL | MP-513 OR PLACEBO (1 IN 1 D) PER ORAL | D | ||||
| 6816514 | 1014082671 | C | CRESTOR | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6816514 | 1014032852 | TYPE 2 DIABETES MELLITUS |
| 6816514 | 1014082670 | TYPE 2 DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6816514 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6816514 | PAIN IN EXTREMITY |
| 6816514 | PROSTATE CANCER |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6816514 | FGN |
| 6816514 | HP |
| 6816514 | SDY |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6816514 | 1014082670 | 20100314 |